Registry study for repeat coronary blockages after stents
Part of Heart & circulation clinical trials.
This study follows adults who have fast, unexplained re-narrowing of a coronary stent, to better understand what causes it and how to monitor it. You may help by allowing the study team to collect medical information over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be age 18 or older
- You must meet the study’s definition of rapid, unexplained stent re-narrowing (RECUR)
- You must be fully told about the study and agree by signing a consent form
- You should not have serious illnesses that are likely to limit life expectancy to under 12 months
- You should not have certain autoimmune/immune system diseases or specific chest pain conditions
- You must be able to attend follow-up visits and be free of significant psychiatric illness
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at real-world outcomes for people with narrowed heart arteries (coronary artery disease). It may include those treated with stents (PCI) or medicines. Doctors will use a special computer tool to measure the severity of blockages and track health over time.
This study tests a new kind of coronary stent that slowly releases rapamycin to keep an artery open. You may be invited if you have a small number of specific, treatable blockages and can take the required blood-thinning medicines.
This study compares two types of coronary artery disease: one linked to inflammation (IR-CAD) and the standard type (AS-CAD). If you have had a heart procedure and were recently hospitalized for worsening chest pain, this study may help doctors understand your condition better.
This study compares how best to place a coronary stent (a small tube to keep an artery open) using modern techniques. It may help improve how safely and effectively stents are delivered in people with certain types of narrowed heart arteries.
This study looks at people whose coronary artery disease worsens quickly despite standard treatment. It compares them to those with stable disease to understand differences and improve care.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.